If you experience joint pain when you walk or move, promises for a quick and inexpensive cure can be hard to resist. But don’t believe the hype. And don’t assume the people you see in the ads are real.
Unlike drugs, joint pain supplements are not evaluated or reviewed by FDA for safety and effectiveness, and supplements claiming to reduce pain and rebuild cartilage might not be proven to work.
Today the FTC announced a settlement against the makers of Synovia, a purported joint pain relief product, for false advertising claims.
The company claims Synovia is “clinically proven” to rebuild damaged cartilage, reduce arthritis pain by 95%, and provide the same joint pain relief as an injected medication. But the FTC says the company doesn’t have scientific support for these claims.
Don’t let false claims cheat you out of your money or your health. Check out this video about questions you can ask when considering any supplement.
And if you spot claims that you think are bogus, tell the FTC: www.ftc.gov/complaint.
It is your choice whether to submit a comment. If you do, you must create a user name, or we will not post your comment. The Federal Trade Commission Act authorizes this information collection for purposes of managing online comments. Comments and user names are part of the Federal Trade Commission’s (FTC) public records system, and user names also are part of the FTC’s computer user records system. We may routinely use these records as described in the FTC’s Privacy Act system notices. For more information on how the FTC handles information that we collect, please read our privacy policy.
The purpose of this blog and its comments section is to inform readers about Federal Trade Commission activity, and share information to help them avoid, report, and recover from fraud, scams, and bad business practices. Your thoughts, ideas, and concerns are welcome, and we encourage comments. But keep in mind, this is a moderated blog. We review all comments before they are posted, and we won’t post comments that don’t comply with our commenting policy. We expect commenters to treat each other and the blog writers with respect.
We don't edit comments to remove objectionable content, so please ensure that your comment contains none of the above. The comments posted on this blog become part of the public domain. To protect your privacy and the privacy of other people, please do not include personal information. Opinions in comments that appear in this blog belong to the individuals who expressed them. They do not belong to or represent views of the Federal Trade Commission.